Anne E OShea
Overview
Explore the profile of Anne E OShea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Decar S, Carpenter E, Adams A, Chick R, Clifton G, Stojadinovic A, et al.
Cancer Treat Res Commun
. 2024 Sep;
41:100843.
PMID: 39305541
Background: The autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine is produced from dendritic cells (DC) loaded ex vivo with autologous tumor lysate (TL). TLPLDC has been shown to decrease...
2.
Wall P, Fassnacht D, Fabry E, OShea A, Houlihan C, Mulgrew K, et al.
J Eat Disord
. 2024 Sep;
12(1):126.
PMID: 39223635
Background: Stigma is a complex construct and its association with help-seeking among those experiencing eating disorders is not well understood. Rates of help-seeking are low for those with eating disorder...
3.
Carpenter E, Van Decar S, McCarthy P, Valdera F, Adams A, OShea A, et al.
J Surg Oncol
. 2024 May;
130(1):109-116.
PMID: 38801055
Background: The benefit of adjuvant therapy (AT) remains unclear in pancreatic ductal adenocarcinoma (PDAC) after neoadjuvant therapy (NAT) and surgical resection. Methods: The 2019 National Cancer Database was queried for...
4.
Fabry E, Fassnacht D, Ford R, Burns N, OShea A, Ali K
Eur Eat Disord Rev
. 2023 Dec;
32(3):450-457.
PMID: 38078569
Objective: This study investigated how self-reliance and denial influence the relationship between help-seeking attitudes and behaviour. Method: Australian university students (N = 406) completed an online survey and females with...
5.
Valdera F, OShea A, Smolinsky T, Carpenter E, Adams A, McCarthy P, et al.
J Surg Oncol
. 2023 Oct;
129(2):244-253.
PMID: 37800378
Introduction: Adjuvant (A) multiagent chemotherapy (MC) is the standard of care for patients with pancreatic adenocarcinoma (PDAC). Tolerating MC following a morbid operation may be difficult, thus neoadjuvant (NA) treatment...
6.
Carpenter E, Van Decar S, Adams A, OShea A, McCarthy P, Chick R, et al.
J Immunother Cancer
. 2023 Aug;
11(8).
PMID: 37536936
Background: The tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine is made by ex vivo priming matured autologous dendritic cells (DCs) with yeast cell wall particles (YCWPs) loaded with autologous tumor...
7.
OShea A, Clifton G, Qiao N, Heckman-Stoddard B, Wojtowicz M, Dimond E, et al.
Cancer Prev Res (Phila)
. 2023 Jun;
16(6):333-341.
PMID: 37259799
Prevention Relevance: This trial showed that vaccination of patients with HLA-A2-positive DCIS with NeuVax in the preoperative setting can induce a sustained antigen-specific T-cell response. This provides proof of principle...
8.
McCarthy P, Valdera F, Smolinsky T, Adams A, OShea A, Thomas K, et al.
Front Immunol
. 2023 Mar;
14:1090533.
PMID: 36960052
Checkpoint inhibitors have invigorated cancer immunotherapy research, including cancer vaccination. Classic early phase trial design and endpoints used in developing chemotherapy are not suited for evaluating all forms of cancer...
9.
OShea A, Nissen A, Bowen D, Barnett T, Gustafson J
J Cardiothorac Surg
. 2022 Oct;
17(1):257.
PMID: 36203172
Background: Primary thymic adenocarcinoma represents an exceptionally rare malignancy, for which the cornerstone of therapy is margin-negative resection, with radiation and systemic therapy reserved for invasive and advanced disease. Thymic...
10.
Adams A, Carpenter E, Clifton G, Vreeland T, Chick R, OShea A, et al.
Cancer Immunol Immunother
. 2022 Aug;
72(3):697-705.
PMID: 36045304
Background: A randomized, double-blind, placebo-controlled phase 2b trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine was conducted in patients with resected stage III/IV melanoma. Dendritic cells (DCs) were...